eCQMs for 2020 Performance Period CMS2v9 CMS22v8 CMS50v8 CMS52v8 CMS56v8 CMS66v8 CMS68v9 CMS69v8 CMS74v9 CMS75v8 CMS82v7 CMS90v9 CMS117v8 CMS122v8 CMS124v8 CMS125v8 CMS127v8 CMS128v8 CMS129v9 CMS130v8 CMS131v8 CMS132v8 CMS133v8 CMS134v8 CMS135v8 CMS136v9 CMS137v8 CMS138v8 CMS139v8 CMS142v8 CMS143v8 CMS144v8 CMS145v8 CMS146v8 CMS147v9 CMS149v8 CMS153v8 CMS154v8 CMS155v8 CMS156v8 CMS157v8 CMS159v8 CMS160v8 CMS161v8 CMS165v8 CMS177v8 CMS249v2 CMS347v3 CMS349v2 CMS645v3 CMS771v1 CMS Measure ID CMS161v8 Version 8 NQF Number 0104e Measure Description Percentage of patients aged 18 years and older with a diagnosis of major depressive disorder (MDD) with a suicide risk assessment completed during the visit in which a new diagnosis or recurrent episode was identified Initial Population All patients aged 18 years and older with a diagnosis of major depressive disorder (MDD) Denominator Statement Equals Initial Population Denominator Exclusions None Numerator Statement Patients with a suicide risk assessment completed during the visit in which a new diagnosis or recurrent episode was identified Numerator Exclusions Not Applicable Denominator Exceptions None Measure Steward PCPI(R) Foundation (PCPI[R]) Domain Effective Clinical Care Previous Version CMS161v7 Measure Scoring Proportion Measure Type Process Improvement Notation Higher score indicates better quality Guidance This measure is an episode-of-care measure and should be reported for each instance of a new or recurrent episode of major depressive disorder (MDD); every new or recurrent episode will count separately in the Initial Population.As the guidelines state, it is important to assess for additional factors which may increase or decrease suicide risk, such as presence of additional symptoms (e.g., psychosis, severe anxiety, hopelessness, severe chronic pain); presence of substance abuse, history and seriousness of previous attempts, particularly, recent suicidal behavior, current stressors and potential protective factors (e.g., positive reasons for living, strong social support), family history of suicide or mental illness or recent exposure to suicide, impulsivity and potential for risk to others, including history of violence or violent or homicidal ideas, plans, or intentions, and putting one's affairs in order (e.g., giving away possessions, writing a will). In addition, although the measure focuses on the initial visit, it is critical that suicide risk be monitored especially for the 90 days following the initial visit and throughout MDD treatment.It is expected that a suicide risk assessment will be completed at the visit during which a new diagnosis is made or at the visit during which a recurrent episode is first identified (i.e., at the initial evaluation). For the purposes of this measure, an episode of major depressive disorder (MDD) would be considered to be recurrent if a patient has not had an MDD-related encounter in the past 105 days. If there is a gap of 105 or more days between visits for major depressive disorder (MDD), that would imply a recurrent episode. The 105-day look-back period is an operational provision and not a clinical recommendation, or definition of relapse, remission, or recurrence.Suicide risk assessments completed via telehealth services can also meet numerator performance.Use of a standardized tool(s) or instrument(s) to assess suicide risk will meet numerator performance. Standardized tools can be mapped to the concept "Intervention, Performed": "Suicide risk assessment (procedure)" included in the numerator logic below.The logic statement for the age requirement, as written, captures patients who turn 18 years old during the measurement period so that these patients are included in the measure, so long as the minimum criteria noted above is evaluated. To ensure all patients with major depressive disorder (MDD) are assessed for suicide risk, there are two clinical quality measures addressing suicide risk assessment; CMS 177 covers children and adolescents aged 6 through 17, and CMS 161 covers the adult population aged 18 years and older, as no individual suicide risk assessment tool or instrument would satisfy the requirements alone. Quality ID 107 Meaningful Measure Prevention, Treatment, and Management of Mental Health Specifications Attachment Size CMS161v8.html 51.15 KB CMS161v8.zip 56.3 KB CMS161v8-TRN.xlsx 21.79 KB Release Notes Header Updated eCQM version number. Measure Section: eCQM Version number Source of Change: Measure Lead Added 'e' to NQF number. Measure Section: NQF Number Source of Change: Standards Update Updated copyright. Measure Section: Copyright Source of Change: Annual Update Updated disclaimer. Measure Section: Disclaimer Source of Change: Measure Lead Updated rationale statement to align with measure updates. Measure Section: Rationale Source of Change: Measure Lead Updated references to align with American Psychological Association (APA) style. Measure Section: Reference Source of Change: Measure Lead Updated references. Measure Section: Reference Source of Change: Measure Lead Updated definition statement for 'Suicide Risk Assessment' to reflect clinical expert recommendations. Measure Section: Definition Source of Change: Measure Lead Updated guidance statement to align with measure changes and per clinical expert recommendations. Measure Section: Guidance Source of Change: Measure Lead Updated guidance statement related to telehealth encounters based on clinical expert recommendations. Measure Section: Guidance Source of Change: Expert Work Group Review Updated parenthetical citations to align with American Psychological Association (APA) style. Measure Section: Multiple Sections Source of Change: Measure Lead Logic Updated the names of Clinical Quality Language (CQL) definitions, functions, and/or aliases for clarification and to align with CQL Style Guide. Measure Section: Definitions and Functions Source of Change: Standards Update Updated ‘Major Depressive Disorder Encounter’ definition to allow for Telehealth Services encounters to meet visit requirements based upon clinical expert recommendations. Measure Section: Multiple Sections Source of Change: Expert Work Group Review Updated Clinical Quality Language (CQL) expression to conform with the HL7 Standard: Clinical Quality Language Specification, Release 1 STU 3 (CQL 1.3). Measure Section: Multiple Sections Source of Change: Standards Update Updated definitions and functions in the Measure Authoring Tool (MAT) Global Common Functions Library to align with standards changes, Clinical Quality Language (CQL) Style Guide, and to include two new functions related to calculating hospital stays. Measure Section: Multiple Sections Source of Change: Standards Update Updated version number of the Measure Authoring Tool (MAT) Global Common Functions Library (MATGlobalCommonFunctions-4.0.000). Measure Section: Multiple Sections Source of Change: Standards Update Value Set The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets. Value set Major Depressive Disorder-Active (2.16.840.1.113883.3.526.3.1491): Added 17 SNOMED CT codes. Measure Section: Terminology Source of Change: Annual Update Value set Psychoanalysis (2.16.840.1.113883.3.526.3.1141): Added SNOMED CT extensional value set (2.16.840.1.113883.3.526.2.1778) including 2 codes. Measure Section: Terminology Source of Change: Annual Update Value set Psych Visit - Diagnostic Evaluation (2.16.840.1.113883.3.526.3.1492): Added SNOMED CT extensional value set (2.16.840.1.113883.3.526.2.1776) including 5 codes. Measure Section: Terminology Source of Change: Annual Update Value set Psych Visit - Psychotherapy (2.16.840.1.113883.3.526.3.1496): Added SNOMED CT extensional value set (2.16.840.1.113883.3.526.2.1777) including 13 codes. Measure Section: Terminology Source of Change: Annual Update Value set Telehealth Services (2.16.840.1.113883.3.464.1003.101.12.1031): Added Telehealth Services. Measure Section: Terminology Source of Change: Annual Update Direct reference code for Birth date (LOINC Code (21112-8)) now displayed in Human Readable. Measure Section: Terminology Source of Change: Annual Update Removed code system versions from direct reference codes. Please refer to Appendix A of the Electronic Clinical Quality Measure Logic and Implementation Guidance document for a list of code system versions used in the eCQM specifications for 2020 reporting/performance. Measure Section: Terminology Source of Change: Standards Update Standardized purpose statement language in value sets across eCQMs. Value set purpose statements are visible in the Value Set Authority Center (VSAC) as well as the downloadable eCQM value set files. Measure Section: Terminology Source of Change: Measure Lead Data Elements contained within CMS161v8 External Resources United States Health Information Knowledgebase NLM Value Set Authority Center (VSAC)